Literature DB >> 32762257

Variations in the Mineral Content of Bottled "Still" Water Across Europe: Comparison of 182 Brands Across 10 Countries.

Simone J M Stoots1, Rob Geraghty2, Guido M Kamphuis1, Enakshee Jamnadass3, Michael M E L Henderickx1, Eugenio Ventimiglia4, Olivier Traxer4, Etienne X Keller5, Vincent DeConinck6, Michele Talso7, Panagiotis Kallidonis8, Esteban Emiliani9, Ewa Bres-Niewada10, Sadaf S Karim3, Angela Picirilli9, Bhaskar K Somani3.   

Abstract

Introduction: Kidney stone disease (KSD) is a highly prevalent disease worldwide. As water intake and its mineral content influence stone formation and recurrence, patients and physicians must be aware of the mineral content of drinkable water. We analyzed commercial bottled still water within Europe to assess the variation in its mineral composition across different manufacturers and countries. Materials and
Methods: Data on the mineral composition of bottled still water regarding bicarbonate, calcium, magnesium, potassium, sodium, and sulfate concentration (mg/L) were collected from ten European countries. To collect the data, the two main supermarket chains in each participating country were either visited to check for the ingredient label on bottles or the online shop was consulted through the website of the supermarket in question. Descriptive statistics such as simple boxplots were used to illustrate the variation in mineral content.
Results: One hundred eighty-two different commercial water brands were analyzed. Up to a fivefold variation in average concentrations per mineral between countries was observed. For calcium, a wide distribution was found in France and Switzerland compared with other countries with calcium levels ranging from 10.5 to 565 mg/L and 8.4 to 579 mg/L, respectively. By consuming 2 L of water with such high calcium levels, the daily reference intake for calcium is already achieved. Conclusions: The mineral content of bottled still water across Europe varies greatly. For patients with KSD it is important to be aware of the mineral content of the water they drink, as it might influence stone recurrence rates and necessitate alterations of their diet.

Entities:  

Keywords:  kidney stone disease; mineral content; mineral water; still water; urolithiasis

Year:  2020        PMID: 32762257     DOI: 10.1089/end.2020.0677

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  6 in total

1.  Variations in the mineral content of bottled 'carbonated or sparkling' water across Europe: a comparison of 126 brands across 10 countries.

Authors:  Simone J M Stoots; Rob Geraghty; Guido M Kamphuis; Enakshee Jamnadass; Michaël M E L Henderickx; Eugenio Ventimiglia; Olivier Traxer; Etienne X Keller; Vincent De Coninck; Michele Talso; Panagiotis Kallidonis; Esteban Emiliani; Ewa Bres-Niewada; Sadaf S Karim; Angela Piccirilli; Athanasios Vagionis; Bhaskar K Somani
Journal:  Cent European J Urol       Date:  2021-02-19

2.  Mineral content variations between Australian tap and bottled water in the context of urolithiasis.

Authors:  Michael Kwok; Stephen McGeorge; Matthew Roberts; Bhaskar Somani; Nicholas Rukin
Journal:  BJUI Compass       Date:  2022-06-20

3.  Variation in Tap Water Mineral Content in the United Kingdom: Is It Relevant for Kidney Stone Disease?

Authors:  Kirolos G F T Michael; Bhaskar K Somani
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

Review 4.  Diet and Stone Disease in 2022.

Authors:  Jessica C Dai; Margaret S Pearle
Journal:  J Clin Med       Date:  2022-08-13       Impact factor: 4.964

Review 5.  Nutrition and Kidney Stone Disease.

Authors:  Roswitha Siener
Journal:  Nutrients       Date:  2021-06-03       Impact factor: 5.717

6.  Global Variations in the Mineral Content of Bottled Still and Sparkling Water and a Description of the Possible Impact on Nephrological and Urological Diseases.

Authors:  Simone J M Stoots; Guido M Kamphuis; Rob Geraghty; Liffert Vogt; Michaël M E L Henderickx; B M Zeeshan Hameed; Sufyan Ibrahim; Amelia Pietropaolo; Enakshee Jamnadass; Sahar M Aljumaiah; Saeed B Hamri; Eugenio Ventimiglia; Olivier Traxer; Vineet Gauhar; Etienne X Keller; Vincent De Coninck; Otas Durutovic; Nariman K Gadzhiev; Laurian B Dragos; Tarik Emre Sener; Nick Rukin; Michele Talso; Panagiotis Kallidonis; Esteban Emiliani; Ewa Bres-Niewada; Kymora B Scotland; Naeem Bhojani; Athanasios Vagionis; Angela Piccirilli; Bhaskar K Somani
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.